ASTELLAS PHARMA A/S: Financial statements 2016
CVR: 10888638
Source: annual report 2016, Danish Business Authority
01/04/2015 – 31/03/2016
ASTELLAS PHARMA A/S (CVR 10888638) has filed annual accounts for 2016. In 2016, the company reported revenue of EUR 155,987,000 and a net result of EUR 6,656,000 compared with EUR 5,258,000 the year before. That is an increase of 27.9% compared with the year before. The profit margin was 4.3%. Equity in the 2016 report amounted to EUR 45,351,000. The solvency ratio was 53%. The company had 118 employees in the financial year.
- Revenue
- EUR 155,987,000
- Profit/Loss
- EUR 6,656,000
- Equity
- EUR 45,351,000
- Total Assets
- EUR 85,538,000
- Employees
- 118
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | 156 mio. EUR | - | 6.7 mio. EUR | 45.4 mio. EUR | 118 |
| 2015 | 121.9 mio. EUR | 25.8 mio. EUR | 5.3 mio. EUR | 38.7 mio. EUR | 116 |
| 2014 | 97 mio. EUR | 26.5 mio. EUR | 7 mio. EUR | 38.4 mio. EUR | 112 |
| 2013 | 93 mio. EUR | 23.6 mio. EUR | 5.7 mio. EUR | 34.4 mio. EUR | 90 |
Official annual report
Find more companies like ASTELLAS PHARMA A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
As of July 6, 2016, Niels Walther-Rasmussen has joined the board of directors of ASTELLAS PHARMA A/S.
As of July 6, 2016, Pedro Møllebro has joined the board of directors of ASTELLAS PHARMA A/S.
As of July 6, 2016, Jan Anders Martin Nordén has joined the board of directors of ASTELLAS PHARMA A/S.
As of July 6, 2016, Nicolaas Jacobus Stander has left the board of directors of ASTELLAS PHARMA A/S.
As of July 6, 2016, Gillian Kay Mitchell has left the board of directors of ASTELLAS PHARMA A/S.
As of July 6, 2016, Mats Stefan Persson has left the board of directors of ASTELLAS PHARMA A/S.
As of July 6, 2016, Jan Anders Martin Nordén is registered as adm. dir. of ASTELLAS PHARMA A/S.
As of July 6, 2016, Mats Stefan Persson has stepped down as adm. dir. of ASTELLAS PHARMA A/S.
As of July 5, 2016, Pedro Møllebro has left the board of directors of ASTELLAS PHARMA A/S.
About ASTELLAS PHARMA A/S
ASTELLAS PHARMA A/S is a Danish company of the type Aktieselskab based in København S, founded in 1987. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named YAMANOUCHI PHARMA A/S and BROCADES PHARMA A/S. The management consists of Mark Andree Dekker. The board consists of Damla Ebru Atilgan (chair), Anne Nymand, Giuseppe Maduri and Mark Andree Dekker. The company is owned by Astellas Pharma Europe LTD.. The company has 67 employees (2026). In 2026, the company reported revenue of EUR 197,863,000 and a net result of EUR 5,229,000 compared with EUR 5,705,000 the year before. Equity in the 2026 report amounted to EUR 20,071,000.